CYP450, COX-2 and Obesity Related Renal Damage
Authors:
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 15 (2) , 125-136
Abstract
The number of obese people in the world is growing rapidly worldwide and has reached epidemic status. Obesity is often associated with the clustering of metabolic and cardiovascular risk factors that contribute to metabolic syndrome or syndrome X. Likewise, metabolic syndrome and its associated traits are major contributing factors to the increase in nephropathy and end stage renal disease. The specific factors that link the metabolic syndrome traits to the progression of nephropathy remain largely unexplored. Recent studies have demonstrated that an imbalance between cyclooxygenase-2 (COX-2) and cytochrome P450 (CYP450) arachidonic acid metabolizing enzymes in the kidney may contribute to the renal damage associated with obesity. Along these lines, COX-2 inhibition decreases renal cytokine levels and glomerular injury in obese rats. Peroxisome proliferators-activated receptors (PPARs) are transcription factors that also contribute to chronic kidney disease in obesity and metabolic syndrome. Intriguingly, interactions between PPARs and arachidonic acid metabolites could be key determinants of renal damage in metabolic syndrome patients. Therefore, there is a promising future for pharmacological agents that manipulate COX-2 and CYP450 metabolites and PPARs to treat obesity related nephropathy.Keywords
This publication has 120 references indexed in Scilit:
- Cyclooxygenase-2 inhibitors: Will they help us prevent diabetic nephropathy?Kidney International, 2002
- Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart diseaseAtherosclerosis, 2001
- Diabetes, Hypertension, and Cardiovascular DiseaseHypertension, 2001
- Weight Gain–Induced Blood Pressure ElevationHypertension, 2000
- NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in RatsHypertension, 2000
- Altered Expression of HepaticCYP2E1andCYP4Ain Obese, Diabeticob/obMice, andfa/faZucker RatsBiochemical and Biophysical Research Communications, 1999
- Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin HypertensionHypertension, 1999
- Hypertension-Induced End-Organ DamageHypertension, 1999
- Massive Obesity and Nephrotic Proteinuria with a Normal Renal BiopsyNephron, 1985
- Blood pressure and hormone changes associated with weight reduction in the obese.Hypertension, 1982